Cell Transfer Therapy for Cancer: Past, Present, and Future
Joint Authors
Qian, Xiaoling
Jin, Hongchuan
Wang, Xian
Source
Journal of Immunology Research
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-01-09
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
Cell transfer therapy for cancer has made a rapid progress recently and the immunotherapy has been recognized as the fourth anticancer modality after operation, chemotherapy, and radiotherapy.
Lymphocytes used for cell transfer therapy include dendritic cells, natural killer (NK) cells, and T lymphocytes such as tumor-infiltrating lymphocytes (TILs) and cytotoxic T lymphocytes (CTLs).
In vitro activated or engineered immune cells can traffic to cancer tissues to elicit persistent antitumor immune response which is very important especially after immunosuppressive treatments such as chemotherapy.
In this review, we overviewed recent advances in the exploration of dendritic cells, NK cells, and T cells for the treatment of human cancer cells.
American Psychological Association (APA)
Qian, Xiaoling& Wang, Xian& Jin, Hongchuan. 2014. Cell Transfer Therapy for Cancer: Past, Present, and Future. Journal of Immunology Research،Vol. 2014, no. 2014, pp.1-9.
https://search.emarefa.net/detail/BIM-1040886
Modern Language Association (MLA)
Qian, Xiaoling…[et al.]. Cell Transfer Therapy for Cancer: Past, Present, and Future. Journal of Immunology Research No. 2014 (2014), pp.1-9.
https://search.emarefa.net/detail/BIM-1040886
American Medical Association (AMA)
Qian, Xiaoling& Wang, Xian& Jin, Hongchuan. Cell Transfer Therapy for Cancer: Past, Present, and Future. Journal of Immunology Research. 2014. Vol. 2014, no. 2014, pp.1-9.
https://search.emarefa.net/detail/BIM-1040886
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1040886